Background Whether hyperthyroidism is an independent risk factor for cardiovascular events remains controversial. We aimed to evaluate the association of overt and subclinical hyperthyroidism with the risk of ischemic heart disease (IHD), stroke, heart failure, and cardiovascular mortality.
Methods Studies regarding the association between hyperthyroidism and cardiovascular events were searched on PubMed and Embase databases. The cardiovascular disease (CVD) risk was classified as high and low, based on pre-existing diseases, including history of coronary, cerebral, or peripheral artery disease; heart failure; atrial fibrillation; diabetes mellitus; or chronic kidney disease.
Results Thirty-seven cohort studies were included in this meta-analysis. The pooled hazard ratio for subjects with overt hyperthyroidism compared with the control group was 1.11 (95% confidence interval [CI], 1.03 to 1.19) for IHD, 1.35 (95% CI, 1.03 to 1.75) for stroke, and 1.20 (95% CI, 1.00 to 1.46) for cardiovascular mortality. For subjects with subclinical hyperthyroidism, the pooled hazard ratio was 1.24 (95% CI, 1.07 to 1.45) for IHD, when compared with the control group. Subgroup analysis by CVD risk showed that the risk of stroke in overt hyperthyroidism was increased in the low CVD risk group; however, these association was not observed in the high CVD risk group. Similarly, the risk of IHD in subjects with subclinical hyperthyroidism was significantly increased in the low CVD risk group.
Conclusion Overt hyperthyroidism is associated with increased risk of IHD, stroke, and cardiovascular mortality, and subclinical hyperthyroidism is associated with increased risk of IHD. These associations were particularly observed in the low risk CVD group without underlying CVD.
Citations
Citations to this article as recorded by
Trends in Prevalence of Thyroid Dysfunction and its Associations With Mortality Among US Participants, 1988-2012 Xiaowen Zhang, Yong Wang, Hongwei Wang, Xinlin Zhang The Journal of Clinical Endocrinology & Metabolism.2024; 109(2): e657. CrossRef
Adequacy of thyroid hormone replacement for people with hypothyroidism in real‐world settings: A systematic review and meta‐analysis of observational studies Agathoklis Efthymiadis, Matthew Henry, Dimitrios Spinos, Marianthi Bourlaki, Alexandros Tsikopoulos, Angeliki Bourazana, Anastasios Bastounis, Konstantinos Tsikopoulos Clinical Endocrinology.2024; 100(5): 488. CrossRef
Thyroid Disorders and Peripheral Arterial Disease Katica Bajuk Studen, Simona Gaberscek, Katja Zaletel, Ales Blinc, Miso Sabovic, Gerit-Holger Schernthaner, Panagiotis Anagnostis, Pier Luigi Antignani, Mojca Jensterle, Dimitri P Mikhailidis, Pavel Poredos Current Vascular Pharmacology.2024; 22(1): 36. CrossRef
Hormonal influences on cerebral aneurysms: unraveling the complex connections Zahra Hasanpour Segherlou, Mahdieh Shakeri, Armin Khavandegar, Sara Stephenson, Kimberly Ciccone, Forough Masheghati, Mohammad Reza Hosseini Siyanaki, Mac Lyerly, Brandon Lucke-Wold Expert Review of Endocrinology & Metabolism.2024;[Epub] CrossRef
Pulmonary Embolism in Patients Admitted With Takotsubo Cardiomyopathy: Prevalence and Associated In-Hospital Adverse Events Omar Elkattawy, Antonia Sames, Sruthi Kunamneni , Riya Sutariya , Mohamed Ismail, Omar Mohamed , Thomas J Lee, Jahanzeb Javed, Sherif Elkattawy, Afif Hossain, Fayez Shamoon Cureus.2024;[Epub] CrossRef
Higher Risk of Incident Hyperthyroidism in Patients With Atrial Fibrillation Pang-Shuo Huang, Jen-Fang Cheng, Jien-Jiun Chen, Yi-Chih Wang, Juey-Jen Hwang, Cho-Kai Wu, Chia-Ti Tsai The Journal of Clinical Endocrinology & Metabolism.2023; 109(1): 92. CrossRef
Eurasian clinical guidelines for the diagnosis and treatment of secondary (symptomatic) forms of arterial hypertension (2022) I. E. Chazova, N. M. Chikhladze, N. V. Blinova, Zh. E. Belaya, N. M. Danilov, E. M. Elfimova, A. Yu. Litvin, L. Ya. Rozhinskaya, N. Yu. Sviridenko, M. Yu. Shvetsov, V. A. Azizov, E. A. Grigorenko, N. P. Mit’kovskaja, I. I. Mustafaev, A. G. Polupanov, A. S Eurasian heart journal.2023; (1): 6. CrossRef
Sympathetic Activation Promotes Cardiomyocyte Apoptosis in a Rabbit Susceptibility Model of Hyperthyroidism-Induced Atrial Fibrillation via the p38 MAPK Signaling Pathway
Jialin Zheng, Shijian Zhao, Qishi Yang, Yantao Wei, Jianmei Li, Tao Guo Critical Reviews in Eukaryotic Gene Expression.2023; 33(5): 17. CrossRef
Cardiovascular outcomes in subclinical thyroid disease: an update Matthew D. Ettleson Current Opinion in Endocrinology, Diabetes & Obesity.2023; 30(5): 218. CrossRef
Lower free triiodothyronine levels are associated with higher all-cause and cardiovascular mortality in people with diabetes-NHANES 2007–2012 Chang Liu, Zhong Xin, Lin Hua Diabetes Research and Clinical Practice.2023; 202: 110811. CrossRef
Hyperthyroidism Sun Y. Lee, Elizabeth N. Pearce JAMA.2023; 330(15): 1472. CrossRef
Is Thyroid Dysfunction Associated with Unruptured Intracranial Aneurysms? A Population-Based, Nested Case–Control Study from Korea Hyeree Park, Sun Wook Cho, Sung Ho Lee, Kangmin Kim, Hyun-Seung Kang, Jeong Eun Kim, Aesun Shin, Won-Sang Cho Thyroid®.2023; 33(12): 1483. CrossRef
Risks of suboptimal and excessive thyroid hormone replacement across ages U. Feldt-Rasmussen, G. Effraimidis, S. Bliddal, M. Klose Journal of Endocrinological Investigation.2023; 47(5): 1083. CrossRef
Association of Mild Thyroid Dysfunction and Adverse Prognosis Among Chinese Patients With Acute ST Segment Elevation Myocardial Infarction Mei-Fang Li, Ze-Tao Wei, Shuai Li, Qi-Ming Feng, Jing-Bo Li Frontiers in Endocrinology.2022;[Epub] CrossRef
The Cardiovascular Effects of Subclinical Hyperthyroidism following Percutaneous Coronary Intervention Ricardo Correa, Ricardo Villela Clinical Thyroidology.2022; 34(6): 240. CrossRef
Weight Gain and Body Composition Changes during the Transition of Thyroid Function in Patients with Graves’ Disease Undergoing Radioiodine Treatment Zhenqin Cai, Qiyu Chen, Yan Ling, Henrik Falhammar International Journal of Endocrinology.2022; 2022: 1. CrossRef
Minor perturbations of thyroid homeostasis and major cardiovascular endpoints—Physiological mechanisms and clinical evidence Patrick Müller, Melvin Khee-Shing Leow, Johannes W. Dietrich Frontiers in Cardiovascular Medicine.2022;[Epub] CrossRef
Role of thyroid hormones-induced oxidative stress on cardiovascular physiology María Laura Barreiro Arcos Biochimica et Biophysica Acta (BBA) - General Subjects.2022; 1866(12): 130239. CrossRef
Yearly Incidence of Stroke and Bleeding in Atrial Fibrillation with Concomitant Hyperthyroidism: A National Discharge Database Study Juqian Zhang, Arnaud Bisson, Grégoire Fauchier, Alexandre Bodin, Julien Herbert, Pierre Henri Ducluzeau, Gregory Y. H. Lip, Laurent Fauchier Journal of Clinical Medicine.2022; 11(5): 1342. CrossRef
Platelet abnormalities in autoimmune thyroid diseases: A systematic review and meta-analysis Yu-tian Cao, Kai-yu Zhang, Jing Sun, Yan Lou, Tian-su Lv, Xinyi Yang, Wen-hui Zhang, Jiang-yi Yu, Qi-biao Wu, Xi-qiao Zhou Frontiers in Immunology.2022;[Epub] CrossRef
Subclinical Hyperthyroidism: A Review of the Clinical Literature Karen Tsai, Angela M. Leung Endocrine Practice.2021; 27(3): 254. CrossRef
Thyroid and heart, a clinically relevant relationship G. Corona, L. Croce, C. Sparano, L. Petrone, A. Sforza, M. Maggi, L. Chiovato, M. Rotondi Journal of Endocrinological Investigation.2021; 44(12): 2535. CrossRef
Antithyroid Drug Treatment in Graves’ Disease Jae Hoon Chung Endocrinology and Metabolism.2021; 36(3): 491. CrossRef
Cardiovascular Outcomes in Thyroid Cancer Patients Treated With Thyroidectomy: A Meta-Analysis Eun Kyung Lee, Hwa Young Ahn, Eu Jeong Ku, Won Sang Yoo, Young Ki Lee, Kee-Hyun Nam, Young Jun Chai, Shinje Moon, Yuh-Seog Jung The Journal of Clinical Endocrinology & Metabolism.2021;[Epub] CrossRef